Table 1 Baseline characteristics of the patients
| Â | Data(n,%) |
|---|---|
Age | Â |
 ≥65 | 80(44.2%) |
 <65 | 101(55.8%) |
Sex | Â |
 Male | 113(62.4%) |
 Female | 68(37.6%) |
Location | Â |
 ≥ 5 cm | 144(79.6%) |
 < 5 cm | 37(20.4%) |
CEA | Â |
 ≥ 5ng/ml | 70(38.7%) |
 < 5ng/ml | 111(61.3%) |
TNM | Â |
 I stage | 38(21.0%) |
 II stage | 57(31.5%) |
 III stage | 86(47.5%) |
PNI | Â |
 Positive | 90(49.7%) |
 Negative | 91(50.3%) |
LVI | Â |
 Positive | 87(48.1%) |
 Negative | 94(51.9%) |
TDs | Â |
 Positive | 22(12.2%) |
 Negative | 159(87.8%) |
Lymph nodes metastasis | Â |
 Yes | 86(47.5%) |
 No | 95(52.5%) |
NLR | Â |
 H-NLR | 38(21.0%) |
 L-NLR | 143(79.0%) |
PLR | Â |
 H-PLR | 153(84.5%) |
 L-PLR | 28(15.5%) |
TLN(median, IQR) | 18(15–22) |